Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
GSK settles vast majority of Zantac claims
GSK settles vast majority of Zantac claims for $2.2 billion
The British drugmaker reached a $2.2 billion settlement to resolve around 80,000 lawsuits over claims its Zantac heartburn remedy causes cancer
GSK agrees to settle about 80,000 Zantac lawsuits for up to $2.2 billion
GSK has agreed to pay up to $2.2 billion to settle most lawsuits in US state courts claiming that a discontinued version of the heartburn drug Zantac caused cancer, the company announced on Wednesday.
GSK surges 6.5% after $2.2 billion Zantac lawsuits settlement
Shares of GSK rose as much as 6.5% on Thursday after the British drugmaker agreed to pay up to $2.2 billion to settle lawsuits in the United States that claimed its discontinued heartburn drug Zantac caused cancer.
Pharmabiz
1m
GSK to resolve 93% of US state court Zantac product liability cases for up to $2.2 billion
GSK
plc announced that it has reached agreements with 10 plaintiff firms who together represent 93% (approximately 80,000) of the
Zantac
(ranitidine) state court product liability cases pending ...
STAT
1d
The company also agreed to pay $70 million to settle a whistleblower lawsuit
GSK has agreed to pay $2.2 billion to settle most of the pending lawsuits that claimed a discontinued version of the Zantac ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
‘New evidence’ emerges
How to help Milton victims
Announces retirement
Benefits set to rise
T-shirt appeal to SCOTUS
Inflation likely cooled again
Internet Archive hacked
Orlando parks reopening
Tax relief to citizens abroad?
Afghan man worked for CIA?
Israel strikes central Beirut
Mayor, wife plead not guilty
To campaign for Harris
COVID-19, flu test OK'd
Pleads guilty to US charges
Nobel Prize in literature
Appeals court weighs fate
Drug-resistant mpox strain
Jobless claims surge
Chemical release at TX plant
GA voter registration ruling
Gateway Pundit settles suit
Approves new Ukraine fund
MD Senate debate takeaways
2M+ infant swings recalled
Judge OKs evidence release
To hold annual nuclear drill
Overseas ballots challenged
Ethel Kennedy dies at 96
Feedback